Kaiser Permanente Roseville Medical Center
In research, Kaiser Permanente Roseville Medical Center stands highest in Health Sciences (#12,670 of 20,462 worldwide), over all time.
- World rank, all time
- #33,863 of 42,892
- Rank in United States
- #7,215 of 8,685
- Research works
- 147 ▲ 27% vs 2013–17
- Citations
- 1.8k 12.2 per fractional work
- Top-10% rate
- 14.3% record average 16.5%
- Open access
- 37% world 28%
What is Kaiser Permanente Roseville Medical Center known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Health SciencesDomain | #12,670 of 20,462 | 14.7% | 125 |
Each strip is that field’s whole ranked pool, with the notch where Kaiser Permanente Roseville Medical Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.
Which keywords describe research at Kaiser Permanente Roseville Medical Center?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Clinical Outcomes, Diagnosis, Treatment, Anticoagulant Therapy, Prognostic Factors, Clinical Practice Guidelines and Guidelines.
- Uveal Melanoma
- Venous Thromboembolism
- Retinal Artery Occlusion
- Ocular Findings
- Prophylaxis
- Metastasis
- ACE2 Receptor
- Management
- Chemotherapy
- Atrial Fibrillation
- Global Burden
- Antithrombotic Therapy
- Neuroimaging
- Radiation Therapy
- Inflammation
- Neurological Disorders
- Clinical Practice Guidelines
- Anticoagulant Therapy
- Clinical Outcomes
- Diagnosis
- Epidemiology
- Treatment
- Risk Factors
- Prognostic Factors
- Guidelines
- Patient Satisfaction
- Genetic Mutations
- Immunosuppressive Therapy
- Quality Improvement
- Cerebral Venous Thrombosis
- Idiopathic Intracranial Hypertension
- Catheter Ablation
- Genomic Analysis
- Pathogenesis
- Healthcare Quality
- Neuroprotection
- Public Reporting
- Pulmonary Embolism
- Robotic Surgery
- Retinoblastoma
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 2.8×33 topics
- Diagnosis3▲ 6.5×15 topics
- Treatment3▲ 4.9×15 topics
- Clinical Outcomes3▲ 26×5 topics
- Risk Factors2▲ 4.6×7 topics
- Anticoagulant Therapy2▲ 38×3 topics
- Prognostic Factors2▲ 10×8 topics
- Clinical Practice Guidelines2▲ 7.9×6 topics
- Guidelines2▲ 9.0×3 topics
- Neurological Disorders2▲ 7.2×9 topics
- Patient Satisfaction2▲ 12×3 topics
- Inflammation2▲ 1.77×11 topics
- Genetic Mutations2▲ 8.2×6 topics
- Radiation Therapy2▲ 28×2 topics
- Immunosuppressive Therapy2▲ 18×4 topics
- Neuroimaging2▲ 12×4 topics
- Quality Improvement2▲ 17×3 topics
- Antithrombotic Therapy1▲ 37×2 topics
- Cerebral Venous Thrombosis1▲ 146×1 topic
- Global Burden1▲ 5.9×6 topics
- Idiopathic Intracranial Hypertension1▲ 146×1 topic
- Atrial Fibrillation1▲ 29×1 topic
- Catheter Ablation1▲ 24×1 topic
- Chemotherapy1▲ 3.9×7 topics
- Genomic Analysis1▲ 12×4 topics
- Management1▲ 3.5×11 topics
- Pathogenesis1▲ 5.5×8 topics
- ACE2 Receptor1▲ 11×2 topics
- Healthcare Quality1▲ 25×1 topic
- Metastasis1▲ 8.0×3 topics
- Neuroprotection1▲ 7.6×4 topics
- Prophylaxis1▲ 21×2 topics
- Public Reporting1▲ 117×1 topic
- Ocular Findings1▲ 82×1 topic
- Pulmonary Embolism1▲ 40×1 topic
- Retinal Artery Occlusion1▲ 82×1 topic
- Robotic Surgery1▲ 17×4 topics
- Venous Thromboembolism1▲ 40×1 topic
- Retinoblastoma1▲ 149×1 topic
- Uveal Melanoma1▲ 149×1 topic
Which research topics does Kaiser Permanente Roseville Medical Center publish most on?
By volume in 2022–2025: Cerebral Venous Sinus Thrombosis, Atrial Fibrillation Management and Outcomes, Patient Satisfaction in Healthcare and Venous Thromboembolism Diagnosis and Management.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cerebral Venous Sinus Thrombosis Neurology 1 works
- 2 Atrial Fibrillation Management and Outcomes Cardiology and Cardiovascular Medicine 1 works
- 3 Patient Satisfaction in Healthcare General Health Professions 1 works
- 4 Venous Thromboembolism Diagnosis and Management Internal Medicine 1 works
- 5 Retinal and Optic Conditions Ophthalmology 1 works
- 6 Ocular Oncology and Treatments Ophthalmology 1 works
- 7 Ocular Diseases and Behçet’s Syndrome Ophthalmology 1 works
- 8 Ovarian cancer diagnosis and treatment Reproductive Medicine 1 works
- 9 Acute Ischemic Stroke Management Epidemiology 1 works
- 10 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Kaiser Permanente Roseville Medical Center's research output changed?
Output in 2018–2022 was 27% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Roseville
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.